Yazar "Byrne, Christopher D." için listeleme
-
The future of International Classification of Diseases coding in steatotic liver disease: An expert panel Delphi consensus statement
Hagstrom, Hannes; Adams, Leon A.; Allen, Alina M.; Byrne, Christopher D.; Chang, Yoosoo; Duseja, Ajay; Gronbaek, Henning; Ismail, Mona H.; Jepsen, Peter; Kanwal, Fasiha; Kramer, Jennifer; Loomba, Rohit; Mark, Henry E.; Newsome, Philip N.; Rinella, Mary E.; Rowe, Ian A.; Ryu, Seungho; Sanyal, Arun; Schattenberg, Joern M.; Serper, Marina; Sheron, Nick; Simon, Tracey G.; Spearman, C. Wendy; Tapper, Elliot B.; Villota-Rivas, Marcela; Wild, Sarah H.; Wong, Vincent Wai-Sun; Yılmaz, Yusuf; Zelber-Sagi, Shira; Aberg, Fredrik; Lazarus, Jeffrey V. (Wiley, 2024)Background:Following the adoption of new nomenclature for steatotic liver disease, we aimed to build consensus on the use of International Classification of Diseases codes and recommendations for future research and ... -
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease
Zhang, Huai; Targher, Giovanni; Byrne, Christopher D.; Kim, Seung Up; Wong, Vincent Wai-Sun; Valenti, Luca; Glickman, Myer; Ponce, Jaime; Mantzoros, Christos S.; Crespo, Javier; Gronbaek, Henning; Yang, Wah; Eslam, Mohammed; Wong, Robert J.; Machado, Mariana Verdelho; Yu, Ming-Lung; Ghanem, Omar M.; Okanoue, Takeshi; Liu, Jun-Feng; Lee, Yong-Ho; Xu, Xiao-Yuan; Pan, Qiuwei; Sui, Meili; Lonardo, Amedeo; Yılmaz, Yusuf; Zhu, Li-Yong; Moreno, Christophe; Miele, Luca; Lupsor-Platon, Monica; Zhao, Lei; LaMasters, Teresa LeAnn; Gish, Robert G.; Nedelcu, Marius; Chan, Wah Kheong; Xia, Ming-Feng; Bril, Fernando; Shi, Jun-Ping; Datz, Christian; Romeo, Stefano; Sun, Jian; Liu, Dan; Sookoian, Silvia; Mao, Yi-Min; Méndez-Sánchez, Nahum; Wang, Xiao-Yan; Pyrsopoulos, Nikolaos T.; Fan, Jian-Gao; Fouad, Yasser; Sun, Dan-Qin; Giannini, Cosimo; Chai, Jin; Xia, Ze-Feng; Jun, Dae Won; Li, Guo-Jing; Treeprasertsuk, Sombat; Li, Ying-Xu; Zhang, Faming; Goh, George Boon-Bee; Furuhashi, Masato; Seto, Wai-Kay; Huang, Hui; Di Sessa, Anna; Li, Qing-Hong; Cholongitas, Evangelos; Zhang, Le; Silveira, Themis Reverbel; Sebastiani, Giada; Adams, Leon A.; Chen, Wei; Qi, Xiaolong; Rankovic, Ivan; De Ledinghen, Victor; Lv, Wen-Jie; Hamaguchi, Masahide; Kassir, Radwan; Müller-Wieland, Dirk; Romero-Gomez, Manuel; Xu, Ying; Xu, Yi-Cong; Chen, Shi-Yao; Kermansaravi, Mohammad; Kuchay, Mohammad Shafi; Lefere, Sander; Parmar, Chetan; Lip, Gregory Y. H.; Liu, Chun-Jen; Åberg, Fredrik; Lau, George; George, Jacob; Sarin, Shiv Kumar; Zhou, Jing-Ya; Zheng, Ming-Hua (Springer, 2024)Background: With the implementation of the 11th edition of the International Classification of Diseases (ICD-11) and the publication of the metabolic dysfunction-associated fatty liver disease (MAFLD) nomenclature in 2020, ... -
Hepatocyte apoptosis fragment product cytokeratin-18 M30 level and non-alcoholic steatohepatitis risk diagnosis: an international registry study
Zhang, Huai; Rios, Rafael S.; Boursier, Jerome; Anty, Rodolphe; Chan, Wah-Kheong; George, Jacob; Yılmaz, Yusuf; Wong, Vincent Wai-Sun; Fan, Jiangao; Dufour, Jean-Francois; Papatheodoridis, George; Chen, Li; Schattenberg, Joern M; Shi, Junping; Xu, Liang; Wong, Grace Lai-Hung; Lange, Naomi F.; Papatheodoridi, Margarita; Mi, Yuqiang; Zhou, Yujie; Byrne, Christopher D.; Targher, Giovanni; Feng, Gong; Zheng, Minghua (Lippincott Williams & Wilkins, 2023)Background:Liver biopsy for the diagnosis of non-alcoholic steatohepatitis (NASH) is limited by its inherent invasiveness and possible sampling errors. Some studies have shown that cytokeratin-18 (CK-18) concentrations may ... -
An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease
Sun, Dan-Qin; Targher, Giovanni; Byrne, Christopher D.; Wheeler, David C.; Wong, Vincent Wai-Sun; Fan, Jian-Gao; Tilg, Herbert; Yuan, Wei-Jie; Wanner, Christoph; Gao, Xin; Long, Michelle T.; Kanbay, Mehmet; Nguyen, Mindie H.; Navaneethan, Sankar D.; Yılmaz, Yusuf; Huang, Yuli; Gani, Rino A.; Marzuillo, Pierluigi; Boursier, Jerome; Zhang, Huijie; Jung, Chan-Young; Chai, Jin; Valenti, Luca; Papatheodoridis, George; Musso, Giovanni; Wong, Yu-Jun; El-Kassas, Mohamed; Mendez-Sanchez, Nahum; Sookoian, Silvia; Pavlides, Michael; Duseja, Ajay; Holleboom, Adriaan G.; Shi, Junping; Chan, Wah-Kheong; Fouad, Yasser; Yang, Junwei; Treeprasertsuk, Sombat; Cortez-Pinto, Helena; Hamaguchi, Masahide; Romero-Gomez, Manuel; Al Mahtab, Mamun; Ocama, Ponsiano; Nakajima, Atsushi; Dai, Chunsun; Eslam, Mohammed; Wei, Lai; George, Jacob; Zheng, Ming-Hua (AME Publishing Company, 2023)Background: With the rising global prevalence of fatty liver disease related to metabolic dysfunction, the association of this common liver condition with chronic kidney disease (CKD) has become increasingly evident. In ... -
An international multidisciplinary consensus statement on MAFLD and the risk of CVD
Zhou, Xiao-Dong; Targher, Giovanni; Byrne, Christopher D.; Somers, Virend; Kim, Seung Up; Chahal, C. Anwar A.; Wong, Vincent Wai-Sun; Cai, Jingjing; Shapiro, Michael D.; Eslam, Mohammed; Steg, Philippe Gabriel; Sung, Ki-Chul; Misra, Anoop; Li, Jian-Jun; Brotons, Carlos; Huang, Yuli; Papatheodoridis, George V.; Sun, Aijun; Yılmaz, Yusuf; Chan, Wah Kheong; Huang, Hui; Mendez-Sanchez, Nahum; Alqahtani, Saleh A.; Cortez-Pinto, Helena; Lip, Gregory Y. H.; de Knegt, Robert J.; Ocama, Ponsiano; Romero-Gomez, Manuel; Fudim, Marat; Sebastiani, Giada; Son, Jang Won; Ryan, John D.; Ikonomidis, Ignatios; Treeprasertsuk, Sombat; Pastori, Daniele; Lupsor-Platon, Monica; Tilg, Herbert; Ghazinyan, Hasmik; Boursier, Jerome; Hamaguchi, Masahide; Nguyen, Mindie H.; Fan, Jian-Gao; Goh, George Boon-Bee; Al Mahtab, Mamun; Hamid, Saeed; Perera, Nilanka; (George, Jacob; Zheng, Ming-Hua (Springer, 2023)Background Fatty liver disease in the absence of excessive alcohol consumption is an increasingly common condition with a global prevalence of similar to 25-30% and is also associated with cardiovascular disease (CVD). ... -
A multi-society Delphi consensus statement on new fatty liver disease nomenclature
Rinella, Mary, E.; Lazarus, Jeffrey V.; Ratziu, Vlad; Francque, Sven M.; Sanyal, Arun J.; Kanwal, Fasiha; Romero, Diana; Abdelmalek, Manal; Anstee, Quentin M.; Arab, Juan Pablo; Arrese, Marco; Bataller, Ramon; Beuers, Ulrich; Boursier, Jerome; Bugianesi, Elisabetta; Byrne, Christopher D.; Castro Narro, Graciela E.; Chowdhury, Abhijit; Cortez-Pinto, Helena; Cryer, Donna; Cusi, Kenneth; El-Kassas, Mohamed; Klein, Samuel; Eskridge, Wayne; Fan, Jiangao; Gawrieh, Samer; Guy, Cynthia D.; Harrison, Stephen A.; Kim, Seung Up; Koot, Bart; Korenjak, Marko; Kowdley, Kris; Lacaille, Florence; Loomba, Rohit; Mitchell Thain, Robert; Morgan, Timothy R.; Powell, Elisabeth; Roden, Michael; Romero-Gomez, Manuel; Silva, Marcelo; Prasad Singh, Shivaram; Sookoian, Silvia C.; Spearman, C. Wendy; Tiniakos, Dina; Valenti, Luca; Vos, Miriam B.; Wong, Vincent Wai-Sun; Xanthakos, Stavra; Yılmaz, Yusuf; Younossi, Zobair; Hobbs, Ansley; Villota-Rivas, Marcela; Newsome, Philip N.; NAFLD Nomenclature consensus group (Elsevier, 2023)The principal limitations of the terms nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are the reliance on exclusionary confounder terms and the use of potentially stigmatising language. ... -
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
Rinella, Mary E.; Lazarus, Jeffrey V.; Ratziu, Vlad; Francque, Sven M.; Sanyal, Arun J.; Kanwal, Fasiha; Romero, Diana; Abdelmalek, Manal F.; Anstee, Quentin M.; Arab, Juan Pablo; Arrese, Marco; Bataller, Ramon; Beuers, Ulrich; Boursier, Jerome; Bugianesi, Elisabetta; Byrne, Christopher D.; Castro Narro, Graciela E.; Chowdhury, Abhijit; Cortez-Pinto, Helena; Cryer, Donna R.; Cusi, Kenneth; El-Kassas, Mohamed; Klein, Samuel; Eskridge, Wayne; Fan, Jiangao; Gawrieh, Samer; Guy, Cynthia D.; Harrison, Stephen A.; Kim, Seung Up; Koot, Bart G.; Korenjak, Marko; Kowdley, Kris V.; Lacaille, Florence; Loomba, Rohit; Mitchell-Thain, Robert; Morgan, Timothy R.; Powell, Elisabeth E.; Roden, Michael; Romero-Gómez, Manuel; Silva, Marcelo; Singh, Shivaram Prasad; Sookoian, Silvia C.; Spearman, C. Wendy; Tiniakos, Dina; Valenti, Luca; Vos, Miriam B.; Wong, Vincent Wai-Sun; Xanthakos, Stavra; Yılmaz, Yusuf; Younossi, Zobair; Hobbs, Ansley; Villota-Rivas, Marcela; Newsome, Philip N. (Elsevier, 2023)The principal limitations of the terms NAFLD and NASH are the reliance on exclusionary confounder terms and the use of potentially stigmatising language. This study set out to determine if content experts and patient ... -
Resmetirom and metabolic dysfunction-associated steatohepatitis: Perspectives on multidisciplinary management from global healthcare professionals
Au, Kahei; Zheng, Ming-Hua; Lee, Wei-Jei; Ghanem, Omar M.; Mahawar, Kamal; Shabbir, Asim; le Roux, Carel W.; Targher, Giovanni; Byrne, Christopher D.; Yılmaz, Yusuf; Valenti, Luca; Sebastiani, Giada; Treeprasertsuk, Sombat; Hui, Hannah Xiaoyan; Sakran, Nasser; Neto, Manoel Galvao; Kermansaravi, Mohammad; Kow, Lilian; Seki, Yosuke; Tham, Kwang Wei; Dang, Jerry; Cohen, Ricardo V.; Stier, Christine; Alsabah, Salman; Oviedo, Rodolfo J.; Chiappetta, Sonja; Parmar, Chetan; Yang, Wah (Springer, 2024)Purpose of ReviewThe approval of resmetirom brings great hope to patients with metabolic dysfunction-associated steatohepatitis (MASH). The purpose of this review is to explore its impact on the global health environment. ... -
The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensus
Zeng, Xu-Fen; Varady, Krista A.; Wang, Xiang-Dong; Targher, Giovanni; Byrne, Christopher D.; Tayyem, Reema; Latella, Giovanni; Bergheim, Ina; Valenzuela, Rodrigo; George, Jacob; Newberry, Carolyn; Zheng, Ju-Sheng; George, Elena S.; Spearman, C. Wendy; Kontogianni, Meropi D.; Ristic-Medic, Danijela; Peres, Wilza Arantes Ferreira; Depboylu, Gamze Yurtdaş; Yang, Wanshui; Chen, Xu; Rosqvist, Fredrik; Mantzoros, Christos S.; Valenti, Luca; Yki-Järvinen, Hannele; Mosca, Antonella; Sookoian, Silvia; Misra, Anoop; Yılmaz, Yusuf; Kim, Won; Fouad, Yasser; Sebastiani, Giada; Wong, Vincent Wai-Sun; Åberg, Fredrik; Wong, Yu Jun; Zhang, Pianhong; Bermúdez-Silva, Francisco-Javier; Ni, Yan; Lupsor-Platon, Monica; Chan, Wah Kheong; Méndez-Sánchez, Nahum; de Knegt, Robert J.; Alam, Shahinul; Treeprasertsuk, Sombat; Wang, Li; Du, Mulong; Zhang, Tiejun; Yu, Ming-Lung; Zhang, Huijie; Qi, Xingshun; Liu, Xin; Pinyopornpanish, Kanokwan; Fan, Yu-Chen; Niu, Kaijun; Jimenez-Chillaron, Josep C.; Zheng, Ming-Hua (Elsevier, 2024)Metabolic dysfunction-associated fatty liver disease (MAFLD) or metabolic dysfunction-associated steatotic liver disease (MASLD), has become the leading cause of chronic liver disease worldwide. Optimal dietary intervention ...
